Poster Abstracts

The deadline to submit an abstract for poster presentations has passed.

Each poster must be a minimum of 36″ x 48″ and cannot exceed 48″ (vertical) x 96″ (horizontal). Poster board assignments and details on poster set-up will be emailed to you in early October.

The Poster Session will be held on Thursday, October 27, 2016, from 8:30pm to 11:00pm in Costa Del Sol ABC. Posters will be arranged in alphabetical order by the presenting author’s last name. Copies of the poster on 11″ x 17″ paper can accompany the poster as handouts but cannot be mounted on the poster boards.

Posters can be set up any time after 5pm on Wednesday, October 26, 2016. All Posters must be removed from poster boards by 10am on Friday, October 28, 2016.

For poster presentation inquiries please contact amiyahira@pcf.org or (310) 570-4705.

Author Abstract Title Download PDF
Abida, Wassim Next generation sequencing of prostate cancer reveals germline and somatic alterations detected at diagnosis and at metastasis that may impact clinical decision making Download PDF
Aggarwal, Rahul A Phase 1b/2 Study of the Oral CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration Resistant Prostate Cancer Download PDF
Alshalalfa, Mohammed PhD A genomic fingerprint for detecting small cell prostate cancer in metastatic and localized disease
Download PDF
Antonarakis, Emmanuel AR-V7 and efficacy of abiraterone and enzalutamide in men with mCRPC: Expanded analysis of the Johns Hopkins cohort Download PDF
Antonarakis, Emmanuel Lytic CD8+ T cell responses to target antigens induced by sipuleucel-T in men with hormone- sensitive and castration-resistant prostate cancer Download PDF
Armstrong, Andrew J. Whole genomic copy number alterations in circulating tumor cells from men with abiraterone or enzalutamide resistant metastatic castration-resistant prostate cancer
Download PDF
Ashab, Hussam Al-Deen Development and validation of novel genomic classifiers for prediction of adverse pathology after prostatectomy
Download PDF
Bevan, Charlotte Amplification-Free Detection of Circulating microRNA Biomarkers from Body Fluids Based on Fluorogenic Oligonucleotide-Templated Reaction between Engineered Peptide Nucleic Acid Probes: Application to Prostate Cancer.
Download PDF
Bismar, Tarek A. Validation of gene expression signatures for genomic identification of neuroendocrine prostate
cancer
Download PDF
Bose, Rohit Loss of Function Mutations in ETS2 Repressor Factor, ERF, Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis
Download PDF
Botta, Ginevra Defining the spectrum of resistance to androgen ablation therapy in prostate cancer
Download PDF
Boysen, Gunther CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair
Download PDF
Brennen, W. Nathaniel Infiltrating Mesenchymal Stem Cells as Cell-based Vectors for Prostate Cancer
Download PDF
Cackowski, Frank Mer Tyrosine Kinase Stimulated Disseminated Prostate Cancer Cellular Dormancy Escape
Download PDF
Cao, Qi A Novel Role of BMI1 in Androgen Receptor Pathway
Download PDF
Chan, Charles K. F. Prospective Isolation and Characterization of Metastatic Prostate Cancer Niche Cells in the Bone Marrow
Download PDF
Cheng, Heather H. Through the Prostate Cancer Looking Glass: characterizing cancer-associated germline mutations by way of prostate cancer family study, registry and prostate cancer genetics clinic
Download PDF
Cieslik, Marcin The landscape and genomic correlates of immune infiltration in 200 metastatic prostate cancers
Download PDF
Coode-Bate, Jack Sulphate Accumulation in Prostate (SAP): A pre-biopsy window-of-opportunity trial to measure sulphate levels in human prostate after broccoli consumption
Download PDF
Crawford, Nigel P.S. Analysis of germline modifiers of aggressive prostate cancer using cross-species variation and systems genetics
Download PDF
Dardenne, Etienne N-Myc induces an EZH2-mediated transcriptional program driving Neuroendocrine Prostate Cancer
Download PDF
Davies, Alastair EZH2 CONTROLS REACTIVATION OF A DORMANT STEM CELL TRANSCRIPTIONAL PROGRAM TO POTENTIATE NEUROENDOCRINE PROSTATE CANCER Download PDF
de Leeuw, Renée Cross-resistance between Cdk4/6 kinase inhibitors and castration in prostate cancer models Download PDF
Dondossola, Eleonora Intravital Microscopy of Prostate Cancer Lesions in Bone: Kinetics of Osteolysis and Therapy Response Download PDF
Downer, Mary K. Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians’ Health Study Download PDF
Drake, Charles Class I HDAC’s regulate T cell inhibitory checkpoint expression and exhaustion Download PDF
Drake, Justin M. Phosphoproteome-Guided Integration Reveals Patient-Specific Signaling Networks in Lethal Prostate Cancer Download PDF
Durack, Jeremy Rapid Spectroscopic Assessment of Prostate Cancer Biopsy Adequacy and Genetic Quantification Download PDF
Efstathiou, Jason A. Long-term results of adjuvant versus early salvage postprostatectomy radiation therapy: a large single institutional experience Download PDF
Ellis, Leigh Rb1 Suppresses Prostate Cancer Metastasis and Lineage Plasticity Underlying Castration Resistance Download PDF
Erho, Nicholas The heterogeneous genomic landscape of low-risk prostate cancer Download PDF
Evans, Michael Measuring oncogene signaling in prostate cancer with transferrin-based PET Download PDF
Feldman, Adam S. Investigation of Prostate Cancer Metabolomics with Prostate Biopsy Cores Download PDF
Feng, Felix Y. Prediction of PARP inhibitor response and resistance utilizing a CTC phenotypic classifer in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC):Results from the NCI 9012 trial Download PDF
Ferrari, Anna Genome-wide alterations in gene expression of prostate cancer (PC) cells surviving neo- adjuvant androgen deprivation therapy (ADT) Download PDF
Fletcher, Claire E. A Novel Role for GSK3? as a Modulator of Drosha Microprocessor Activity and MicroRNA Biogenesis Download PDF
Freeman, Michael R. ONECUT2 IS A MASTER REGULATOR TRANSCRIPTION FACTOR AND NOVEL DRUG TARGET IN AGGRESSIVE PROSTATE CANCER VARIANTS Download PDF
Gao, Allen C. Targeting androgen receptor variants by niclosamide overcoming resistance to abiraterone and enzalutamide Download PDF
Garraway, Isla Quantitative Digital Image Analysis Accurately Identifies Bone Metastatic Prostate Tumors Based Upon Histomorphometric and Nuclear Features of Diagnostic Prostate Needle Biopsies Download PDF
Gibb, Ewan A. Low expression of PCA3 in localized prostate tumors is associated with clinical recurrence and metastatic progression Download PDF
Gioeli, Daniel Checkpoint Kinase 2 and Androgen Receptor Function in Prostate Cancer. Download PDF
Golsorkhi, Tony Trial of RucaparIb in ProsTate IndicatiONs-2 (TRITON-2): A Multicenter, Open-Label Phase 2 Study of the PARP Inhibitor Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer Associated with Homologous Recombination Deficiency (HRD) Download PDF
Gomez, Christian R. MHC CLASS I POLYPEPTIDE RELATED A (MICA) AS MARKER OF AGGRESSIVE PROSTATE CANCER. Download PDF
Gross, Mitchell E. Digital Microscopy Evaluation of Cellular proliferation, Vascularization, and Gleason grade. Download PDF
Gross, Mitchell Interim Analysis of Phenelzine (a Monoamine Oxidase Inhibitor) for Non-metastatic Recurrent Prostate Cancer Download PDF
Gueron, Geraldine Heme Oxygenase -1 (HO-1) in the forefront of a multi-molecular network that governs cell-cell contacts and filopodia-induced zippering in prostate cancer
Download PDF
Haber, Daniel A. RNA profiling of circulating tumor cells to monitor prostate cancer
Download PDF
Haddad, Zaid Decipher correlation patterns on biopsy: Initial experience from 738 prospective patients
Download PDF
Hargrove, Amanda E Targeting the lncRNA SChLAP1 in aggressive prostate cancer by the assembly of multivalent small molecule inhibitors
Download PDF
Harshman MD, Lauren C. An investigator-initiated phase I study of crizotinib in combination with enzalutamide in metastatic castration-resistant prostate cancer (mCRPC) before or after progression on docetaxel
Download PDF
He, Bin The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker
Download PDF
Heaphy, Christopher M. Generating and characterizing novel prostate cancer cell lines that employ the Alternative Lengthening of Telomeres (ALT) telomere maintenance mechanism
Download PDF
Hearn, Jason HSD3B1 and Resistance to Androgen Deprivation Therapy in Prostate Cancer Download PDF
Henning, Susanne M. Effect of dietary omega-3 fatty acids on tumor-associated macrophages and prostate cancer progression Download PDF
Hope, Thomas A. Ga-PSMA-11 in Intermediate to High-Risk Preprostatectomy Patients Download PDF
Huang, Haojie Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration- Resistant Prostate Cancer Download PDF
Ippolito, Joseph E. Characterization of Lactate Metabolism in Neuroendocrine Prostate Cancer Download PDF
Jamieson, Christina Genomic analysis of a longitudinal series of surgical prostate cancer bone metastases and xenografts from the same patient revealed selection of a progressively therapy-resistant metastatic clone. Download PDF
Jarrard, David F. A personalized medicine approach to identifying dysregulated epigenetic enzymes in the development of castrate-resistant prostate cancer Download PDF
Kaittanis, PhD, Charalambos Therapy Optimization to Prevent Resistance in Prostate Cancer using Molecular Inflection Points and Clinical Nanocarriers Download PDF
Karnes, R. Jeffrey Tumor draining lymph nodes in prostate cancer harbor immune suppressor cells that may impair tumor-reactive T cells Download PDF
Karow, David S. Voxel Level Radiologic-Pathologic Validation of Restriction Spectrum Imaging Cellularity Index with Gleason Grade in Prostate Cancer Download PDF
Kibel, Adam Decipher Test Impacts Treatment Decision-Making among Patients with Biochemical Recurrence after Radical Prostatectomy: Results from the Multicenter Prospective PRO- IMPACT study Download PDF
Kim, Won Dehydroepiandrosterone (DHEA) as a biomarker for subsequent therapy in metastatic castration-resistant prostate cancer (mCRPC): preliminary results from the SU2C-PCF West Coast Dream Team (WCDT). Download PDF
Kloss, Christopher C. TGF? Signaling Blockade Enhances the Functionality of PSMA Targeted CAR Human T Cells for the Eradication of Metastatic Prostate Cancer Download PDF
Kothari, Vishal Investigating DNAPK as a therapeutic target and a prognostic biomarker in castration-resistant prostate cancer. Download PDF
Kulkarni, Rajan Utilizing Vortex Chip for Enumeration and Determination of Single-Cell Heterogeneity of Circulating Tumor Cells in Prostate Cancer Download PDF
Kyriakopoulos, Christos E. Pilot trial of neoadjuvant combination androgen deprivation, AR-targeted vaccination, and PD-1 blockade in patients with newly diagnosed prostate cancer Download PDF
Labbé, David P. Diet-induced obesity enhances MYC-driven prostate cancer through metabolic and epigenetic rewiring Download PDF
LeBeau, Aaron M. Targeting Urokinase Plasminogen Activator for Radioimmunotherapy Using an Internalizing Human Antibody Download PDF
Lee, John K. Combined gene expression and cell surface proteomics identifies potential therapeutic targets for subtypes of advanced prostate cancer Download PDF
Lehrer, Jonathan Coupling in vitro drug sensitivity data with whole-transcriptome expression profiles allows
for prediction of patient specific response to individual drugs.
Download PDF
Li, Zhenfei Abiraterone metabolism in castration resistant prostate cancer Download PDF
Lin, Daniel Decipher Test Impacts Adjuvant Treatment Decision-Making among Patients with High-Risk Pathology at Radical Prostatectomy: Results from the Multicenter Prospective PRO- IMPACT Study Download PDF
Linder PhD, Karen E. Performance of fluciclovine F 18 in men with recurrent prostate cancer Download PDF
Loda, Massimo Inhibition of fatty acid synthase suppresses the androgen receptor and its splice variant V7 and reduces castration resistant prostate cancer growth. Download PDF
Loeb, MD MSc, Stacy Informational Needs During Active Surveillance for Prostate Cancer: A Qualitative Study Download PDF
Lotan, Tamara L. Gene Expression Meta-Signature of Neuroendocrine Prostate Cancer Download PDF
Lupold, Shawn E. Identification of miR-30b-3p and miR-30d-5p as direct regulators of Androgen Receptor Signaling in Prostate Cancer by complementary functional microRNA library screening Download PDF
Macias, Everardo In vivo genomic screen identifies RIOK2 as a mediator of obesity enhanced prostate cancer growth. Download PDF
Madan, Ravi A. Studies to Evaluate the Immunologic Impact of Radium-223 in Patients with Prostate Cancer Download PDF
Maher, Christopher A. Multi-institutional analysis shows low PCAT-14 expression associates with poor outcome in prostate cancer Download PDF
Malek, Reem Sensitization to PARP Inhibition by Co-Targeting TWIST1-HOXA9 in Prostate Cancer Download PDF
Markowski, Mark IDENTIFICATION OF AR -INDEPENDENT MECHANISMS OF ACTION OF BETI IN A NOVEL MURINE MODEL OF PROSTATE CANCER Download PDF
Markt, Sarah C. Disruption of the circadian rhythm and advanced prostate cancer Download PDF
Mateo, Joaquin Targeted sequencing for molecular stratification of matched primary tumor samples and metastatic biopsies in castration-resistant prostate cancer. Download PDF
McBride, MD, MPH, Sean M. ARN-509+Abiraterone acetate+Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation (AASUR) in Very High Risk Prostate Cancer: A Single Arm, Phase II Study Download PDF
McGuire, Sean E. Targeting the Mitochondrial Pyruvate Carrier in Castration-Resistant Prostate Cancer Download PDF
McKay, Rana R. A phase II trial of abiraterone combined with dutasteride for men with metastatic castration-resistant prostate cancer. Download PDF
Mehra, Niven Myeloid-derived suppressor cells (MDSCs) in metastatic castration-resistant prostate cancer (CRPC) patients Download PDF
Mills, Ian G. Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer Download PDF
Mitrofanova, Antonina Systems biology approach to predict optimal therapeutic strategies for aggressive prostate cancer Download PDF
Miyamoto, David T. A digital expression signature of circulating tumor cells to monitor prostate cancer Download PDF
Montie, Heather L. Investigating the role of androgen receptor acetylation in castrate-resistant prostate cancer
Download PDF
Morgan, Todd M. Identification of a CTC-based prognostic signature in mCRPC driven by Aurora Kinase A and Wnt signaling
Download PDF
Mucci, Lorelei A. Amine and lipid metabolites are enriched in advanced prostate cancer Download PDF
Nguyen, Hao G. Protein synthesis dependent activation of the unfolded protein response enables prostate cancer development and a druggable target for cancer therapy Download PDF
Nguyen, Hao G. Validation of GEMCaP as a DNA based biomarker to predict disease recurrence in patients with intermediate to high risk disease undergoing prostatectomy for prostate cancer Download PDF
Nickols, Nicholas G. A pyrrole-imidazole polyamide is active against enzalutamide resistant prostate cancer Download PDF
Nonn, Larisa Analyses of the vitamin D axis in serum and prostate tissues from African American and Caucasian men reveals that ancestry associates with differences in local regulation of the active hormone in the prostate Download PDF
Olmos, David GERMLINE DNA REPAIR DEFECTS IN A PROSPECTIVE MULTICENTER COHORT OF METASTATIC CRPC PATIENTS: A INTERIM ANALYSIS OF THE PROREPAIR STUDY Download PDF
Olson, Brian A DNA vaccine encoding the androgen receptor ligand binding domain enhances antigen-specific immune responses in prostate cancer patients Download PDF
Olumi, Aria F. Androgenic to estrogenic switch due to epigenetic silencing of steroid 5-? reductase 2 Download PDF
Papo, Niv Combinatorial Engineering of Proteolytically Resistant APPI Variants that Inhibit Human Mesotrypsin for Prostate Cancer Therapy
Download PDF
Puca, Loredana Patient-derived organoid models of neuroendocrine prostate cancer Download PDF
Qiao, Yuanyuan Development of a rational triple combination therapy for castrate-resistant prostate cancer Download PDF
Ricci, Deborah S. Circulating tumor cell (CTC) analysis of biomarkers and outcomes in Japanese metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate plus prednisone Download PDF
Ross, Ashley E. Combinatorial Therapeutic Approaches with PD-1 Inhibition in Prostate Cancer Download PDF
Rowe, Steven P. Clinical Utility of Prostate-Specific Membrane Antigen-Targeted Imaging in Men with Prostate Cancer. Download PDF
Salami, Simpa S. The Clonal Origin of Lymph Node Metastasis in Multifocal Prostate Cancer: Defining the Biologically Dominant Nodule Download PDF
Sartor, Oliver Eradication of AR and MYC Amplifications, and Re-Sensitization to Abiraterone, by High Dose Testosterone in a CRPC Patient Download PDF
Scher, Howard I. Impact of AR-V7 protein localization in the prediction of therapeutic benefit of Taxanes over Androgen Receptor Signaling inhibitors (ARSi) in metastatic Castration Resistant Prostate Cancer (mCRPC) Download PDF
Schiewer, Matthew J. PARP1-mediated E2F1 regulation of DNA repair capacity Download PDF
Scholz, Mark Phase I Clinical Trial of Sipuleucel-T Combined with Escalating Doses of Ipilimumab (SIPIPI) in Progressive Metastatic Castrate-Resistant Prostate Cancer Download PDF
Schultz, Nikolaus The long tail of significantly mutated genes in prostate cancer Download PDF
Schweizer, Michael T. Mismatch Repair Deficiency is Common in Ductal Adenocarcinoma of the Prostate Download PDF
Selth, Luke A. GATA2-regulated miR-194 targets Suppressor of Cytokine Signaling 2 to promote prostate cancer metastasis Download PDF
Shah, Neel Epigenetic regulation of the glucocorticoid receptor drives drug resistance in prostate cancer Download PDF
Shalapour, Shabnam Potentiation of the Cancer Immunotherapy with low dose chemotherapy Download PDF
Sharp, Adam Targeting the druggable interaction between the N-terminal domain of the androgen receptor (AR) and BAG-1L, a key regulator of AR function. Download PDF
Shi, Jinjun Systemic Delivery of Nucleic Acids for Prostate Cancer Therapy Download PDF
Simone, Nicole Caloric restriction reduces inflammation to decrease prostate cancer growth and metastases in several prostate cancer models Download PDF
Smith, Bryan A. Single Cell Analysis of Normal Basal Cells Reveals Cellular Heterogeneity and Link to Aggressive Prostate Cancer Phenotypes Download PDF
Somarelli, Jason A. Mechanistic and functional interplay between epithelial plasticity and androgen receptor in driving enzalutamide resistance Download PDF
Sowalsky, Adam G. Gleason score 7 prostate cancers emerge through branched evolution of clonal Gleason pattern 3 and 4 Download PDF
Spratt, Daniel E. Individual Patient Level Meta-analysis of the Performance of the Decipher Genomic
Classifier in High Risk Men Post-Prostatectomy to Predict Development of Metastatic Disease
Download PDF
Stein, Mark N. Patient-derived hormone naive prostate cancer organoids to test responsiveness to therapy Download PDF
Stephan, Matthias T. In vivo programming of prostate tumor-specific T-cells using synthetic nanoparticles Download PDF
Stoyanova, Tanya Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer Download PDF
Stuart, Joshua M. Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer Download PDF
Szmulewitz, Russell Z Genomewide analysis of AR and GR chromatin occupancy and associated mRNA expression in enzalutamide-treated GR+ prostate cancer (PC) cells +/- selective glucocorticoid receptor modulators (SGRM) treatment Download PDF
Takhar, Mandeep Transcriptome wide analysis of MRI-targeted biopsy and matching surgical specimens from high-risk prostate cancer patients treated with radical prostatectomy Download PDF
Theuer, Charles Development of a small molecule inhibitors targeting androgen receptor (AR) mutations associated with resistance to current AR antagonists Download PDF
Thorek, Daniel LJ Exploiting FcRn-mediated Antibody Internalization for Targeted Imaging and Directed Therapy of Androgen Receptor Controlled Secreted Enzymes Download PDF
Tien, Jean Ching-Yi Characterization of prostate cancer-associated transcript 47 as a novel prostate cancer oncogene and therapeutic target Download PDF
Tran, Phuoc Stereotactic Ablative Radiation Therapy for the Treatment of Oligometastatic Prostate Cancer Download PDF
Trinh, Quoc-Dien Cognitive Effects of Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis Download PDF
True, Lawrence 3D Pathology: Use of Clarity & Light-sheet Microscopy to More Accurately Grade & Stage Unfixed Prostate Carcinoma Download PDF
Tsai, Hung-Ji Targeting karyotypic heterogeneity in aneuploid populations Download PDF
Ulmert, H. David S. Exploiting FcRn-mediated Antibody Internalization for Targeted Imaging and Directed Therapy of Androgen Receptor Controlled Secreted Enzymes Download PDF
VanderWeele, David J. Treatment-naïve, locally advanced prostate cancer contains numerous subclonal clinically significant alterations Download PDF
Wang, Qiqi Evaluation of the Decipher prostate cancer classifier to predict metastasis and disease- specific mortality from genomic analysis of diagnostic prostate needle biopsy specimens Download PDF
Wilson, Kathryn M. Baseline Prostate-specific antigen (PSA) levels in midlife predict aggressive prostate cancer in African-American men Download PDF
Wu, Jennifer Antibody targeting soluble NKG2D ligand sMIC remarkably enhances CTLA4 blockade therapy for metastatic prostate cancer in pre-clinical models Download PDF
Yadav, Kamlesh A multiscale survey of inflammatory diseases and prostate oncophenotypes. Download PDF
Yadav, Shalini S. Inflammatory response of tumor associated lymphocytes promotes EMT in prostate cancer Download PDF
Yamoah, M.D, Ph.D., Kosj Clinical implications of TMPRSS2-ERG fusion in African American men with localized prostate cancer Download PDF
Yang, Rendong ScanIndel: a novel and versatile indel caller for next generation sequencing in cancer research and clinical applications Download PDF
Ye, Huihui Resistance Mechanisms in Prostate Cancer after Neoadjuvant Intense Androgen Deprivation Therapy Download PDF
Zarif, Jelani C. TARGETING M2-TUMOR ASSOCIATED MACROPHAGES IN PROSTATE CANCER Download PDF
Zhao, Shuang G. Luminal and basal subtyping of prostate cancer is prognostic and predicts response to androgen deprivation therapy Download PDF
Zhao, Shuang G. Development and Validation of a 24-gene Predictor of Response to Post-operative Radiation Therapy in Prostate Cancer Download PDF
Zurita, Amado J. A clinically applicable strategy to concurrently profile prostate cancer (PCa) in circulation and bone using high-definition single cell analysis (HD-SCA) Download PDF
Zwart, Wilbert Epigenetics in prostate cancer: from prognostication to tailored therapy Download PDF